FLSM
PASG icon

Frazier Life Sciences Management’s Passage Bio PASG Stock Holding History

Frazier Life Sciences Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-87,911
Closed -$1.16M – 52
2023
Q3 		$1.16M Sell
87,911
-4,589
-5% -$75.4K 0.08% 51
2023
Q2 		$1.74M Sell
92,500
-95,346
-51% -$1.89M 0.1% 47
2023
Q1 		$3.6M Hold
187,846
– – 0.26% 45
2022
Q4 		$5.18M Hold
187,846
– – 0.32% 38
2022
Q3 		$4.7M Sell
187,846
-62,615
-25% -$2.47M 0.36% 36
2022
Q2 		$11.8M Hold
250,461
– – 1.12% 24
2022
Q1 		$15.5M Buy
+250,461
New +$20.6M 1.32% 25

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return